H3K27ac-induced IFITM3 promotes progression of TNBC and resistance to anti-PD-1/PD-L1 therapy via the TNF-α/NF-κB/PD-L1 axis
Fields of Study & Subjects
NF-κB Signaling Pathways
interferon and immune responses
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Volume
- 1872
- Issue
- 6
- Pages
- 168238–168238
- Publication date
- 1 April 2026
- Language
- EN